We are monitoring the impact of COVID-19 & Recession alarm on Europe Autoimmune Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

Europe Autoimmune Diagnostics Market Research Report – Segmented By Test Type, Disease Type, End User and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Industry Size, Share, Trends, Growth, Forecast (2022 to 2027)

Published: January, 2022
ID: 1127
Pages: 134

Europe Autoimmune Diagnostics Market Size (2022 to 2027)

The size of the Autoimmune Diagnostics Market in Europe was worth USD 3.78 billion in 2022 and estimated to reach USD 4.54 billion by the end of 2027, growing at a CAGR of 3.76%.

Autoimmune diseases arise once the immune system attacks one or more of the body's normal parts as if they were invaders. When the immune system fails to identify "self" it may produce immune cells or antibodies that target its own tissues, cells, and organs. Developed countries of Europe have a projected high occurrence rate of autoimmune disorders compared to other regions of the autoimmune disease diagnostics. The strike rate of autoimmune diseases is more in women compared to men. The presence of large untapped opportunities available in the developing Eastern European countries is expected to fuel the growth of the market.

High occurrence of autoimmune disorders, Supportive government policies, increasing public awareness, increased government funding aimed at improving healthcare infrastructure, the introduction of advanced technologies such as novel biomarkers and portable diagnostic equipment are the major factors driving the growth of the market.

The key restraints that inhibiting the growth of the autoimmune diagnostics market are the low prevalence of localized autoimmune disorders as compared to systemic diseases and the growing rate of diagnostics errors.

This research report is on the European Autoimmune diagnostics market has been segmented & sub-segmented into the following categories:

By Test Type:

  • Autoantibody Tests
  • Antinuclear Antibody Tests
  • Complete Blood Count (CBC)
  • C-reactive protein (CRP) 
  • Comprehensive Metabolic panel  
  • Urinalysis 
  • Erythrocyte Sedimentation Rate (ESR)     
  • Others

By Disease Type:

  • Localized autoimmune disease diagnostics
    • Graves' Disease
    • Hashimoto's Thyroiditis
    • Multiple Sclerosis
    • Type 1 diabetes
    • Psoriasis
    • Others
  • Systemic autoimmune disease diagnostics
    • Rheumatoid Arthritis (RA)
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)

By End User:

  • Hospitals
  • Research Centres
  • Diagnostic Laboratories

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Companies leading the European Autoimmune disease market profiled in this report are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli Lilly and GlaxoSmithKline Plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 U.K

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Autoimmune Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  2. Europe Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  3. Europe Autoantibody Tests Market, By Region, From 2022 - 2027 (USD Billion)
  4. Europe Antinuclear Antibody Tests Market, By Region, From 2022 - 2027 (USD Billion)
  5. Europe Complete Blood Count (CBC) Market, By Region, From 2022 - 2027 (USD Billion)
  6. Europe C - reactive protein (CRP) Market, By Region, From 2022 - 2027 (USD Billion)
  7. Europe Comprehensive Metabolic panel Market, By Region, From 2022 - 2027 (USD Billion)
  8. Europe Urinalysis Market, By Region, From 2022 - 2027 (USD Billion)
  9. Europe Erythrocyte Sedimentation Rate (ESR) Market, By Region, From 2022 - 2027 (USD Billion)
  10. Europe Other Test Types Market, By Region, From 2022 - 2027 (USD Billion)
  11. Europe Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  12. Europe Localized Autoimmune Diseases Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  13. Europe Systemic Autoimmune Diseases Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  14. U.K Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  15. U.K Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  16. Spain Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  17. Spain Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  18. Germany Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  19. Germany Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  20. Italy Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  21. Italy Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  22. France Autoimmune Diagnostics Market, By Test Type, From 2022 - 2027 (USD Billion)
  23. France Autoimmune Diagnostics Market, By Disease Type, From 2022 - 2027 (USD Billion)
  24. Europe Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  25. Europe Graves' Disease Market, By Region, From 2022 - 2027 (USD Billion)
  26. Europe Hashimoto's Thyroiditis Market, By Region, From 2022 - 2027 (USD Billion)
  27. Europe Multiple Sclerosis Market, By Region, From 2022 - 2027 (USD Billion)
  28. Europe Type 1 diabetes Market, By Region, From 2022 - 2027 (USD Billion)
  29. Europe Psoriasis Market, By Region, From 2022 - 2027 (USD Billion)
  30. Europe Other Localized Autoimmune Diagnostics Market, By Region, From 2022 - 2027 (USD Billion)
  31. U.K Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  32. Spain Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  33. Germany Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  34. Italy Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  35. France Localized Autoimmune Disease Diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  36. Europe Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  37. Europe Rheumatoid Arthritis (RA) Market, By Region, From 2022 - 2027 (USD Billion)
  38. Europe Ankylosing Spondylitis Market, By Region, From 2022 - 2027 (USD Billion)
  39. Europe Systemic Lupus Erythematosus (SLE) Market, By Region, From 2022 - 2027 (USD Billion)
  40. U.K Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  41. Spain Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  42. Germany Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  43. Italy Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)
  44. France Systemic Auto-immune disease diagnostics Market, By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample